News in brief: Losses widen for Avecho and Elixinol; InhaleRx secures HREC approval; Zelira cuts deficit; Argent shifts from ‘non-core’ activities by Adam Sheldon August 29, 2025September 4, 2025 Health food business Elixinol Wellness reported a loss after tax of A$3.1 million in the six […]
InhaleRx reports half-year loss but advances clinical trial plans by Martin Lane August 26, 2025August 28, 2025
